We thus examined whether the targets of DNase I could be tumor‐derived NETs in blood plasma since high levels of NETs and decreased DNase activity of blood plasma have been found in patients with metastatic cancers [37, 38]. This evidence concerns the gene DNASE1 and metastatic malignant neoplasm.